Our Pricing

Ozempic to Mounjaro Conversion - All Doses Available

If you're considering ozempic to mounjaro conversion uk, understanding the correct dose transition is essential for maintaining your weight loss progress. At Cured Pharmacy, our UK-registered prescribers guide patients through safe medication switches with personalised dosing based on your current Ozempic regimen and clinical response.

Understanding Ozempic to Mounjaro Conversion UK: Why Patients Switch

Many patients switch from Ozempic (semaglutide) to Mounjaro (tirzepatide) after reaching a plateau or seeking enhanced weight loss results. Whilst Ozempic activates GLP-1 receptors alone, Mounjaro is the UK's first dual GIP/GLP-1 receptor agonist, engaging two metabolic pathways simultaneously [1]. This dual mechanism has demonstrated superior weight reduction in head-to-head trials.

In the SURPASS-2 trial comparing tirzepatide directly with semaglutide 1mg, patients on the highest tirzepatide dose achieved up to 15.7kg average weight loss compared to 6.7kg with semaglutide over 40 weeks [1]. This significant difference drives many UK prescribers to recommend conversion for patients who have stabilised on Ozempic but wish to optimise their outcomes.

The decision to switch should always involve a clinical assessment. Your UK prescriber at Cured Pharmacy will evaluate your current dose, weight loss trajectory, tolerability, and medical history before recommending Mounjaro as an appropriate next step. Conversion is not automatic—it requires individualised prescriber approval based on your specific circumstances.

Ozempic to Mounjaro Dose Conversion Chart

There is no direct milligram-for-milligram equivalence between Ozempic and Mounjaro because they work through different receptor mechanisms. However, UK prescribers typically follow MHRA-approved titration schedules when transitioning patients. The standard approach is to start Mounjaro at the initial 2.5mg dose regardless of your current Ozempic strength, allowing your body to adapt to the dual-agonist mechanism [2].

Most patients currently on Ozempic 0.5mg, 1mg, or 2mg will begin Mounjaro at 2.5mg weekly for four weeks, then escalate to 5mg for the next four weeks. Your prescriber will then assess tolerability and efficacy before progressing to higher maintenance doses of 7.5mg, 10mg, 12.5mg, or the maximum 15mg as clinically appropriate [2]. This gradual titration minimises gastrointestinal side effects whilst optimising metabolic benefits.

The MHRA-licensed dosing schedule differs from a simple conversion chart because tirzepatide's dual mechanism requires a fresh titration pathway. Patients should not assume their Ozempic dose directly translates to an equivalent Mounjaro strength—your UK prescriber will determine the appropriate escalation based on your individual response and tolerance during the initial weeks.

Starting Mounjaro After Ozempic: Timing Considerations

When switching from Ozempic to Mounjaro, timing depends on your current injection schedule. Because Ozempic has a half-life of approximately one week, most UK prescribers recommend starting Mounjaro one week after your final Ozempic dose to avoid overlapping drug exposure [3]. This interval prevents excessive GLP-1 receptor stimulation whilst maintaining therapeutic continuity.

Your prescriber may adjust this timeline if you experience side effects or have specific clinical factors. Some patients benefit from a slightly longer washout period, particularly if they experienced significant nausea on higher Ozempic doses. The free consultation at Cured Pharmacy ensures your transition is planned around your individual needs and medical history.

What to Expect When Switching from Ozempic to Mounjaro

During the first four weeks on Mounjaro 2.5mg, many patients report similar appetite suppression to their previous Ozempic dose, though some notice enhanced satiety due to the additional GIP receptor activation. Gastrointestinal adaptation is common—nausea, mild diarrhoea, or constipation may occur as your body adjusts to the dual-agonist mechanism, even if you tolerated Ozempic well [2].

Weight loss typically continues or accelerates once you reach the 5mg dose and beyond. In clinical trials, the majority of tirzepatide-related weight reduction occurred between weeks 12 and 36, with patients on maintenance doses of 10mg or 15mg achieving average reductions of 19.5% to 22.5% of baseline body weight over 72 weeks [1]. Your UK prescriber will monitor your progress and adjust dosing to balance efficacy with tolerability.

It's essential to maintain realistic expectations during conversion. Not every patient will tolerate or require the maximum 15mg dose—many achieve excellent results on 7.5mg or 10mg maintenance doses. Your prescriber at Cured Pharmacy will work with you to find the optimal strength that delivers meaningful weight loss without compromising quality of life due to side effects.

Managing Side Effects During the Transition

If you experience nausea or gastrointestinal discomfort when starting Mounjaro, eating smaller, more frequent meals and avoiding high-fat foods can help. These side effects typically diminish within the first few weeks as your body adapts. If symptoms persist or worsen, contact your prescriber—they may slow your dose escalation schedule or provide additional management strategies.

Staying well-hydrated is particularly important during the transition, as GLP-1 and GIP agonists can slow gastric emptying. Aim for at least two litres of water daily and monitor for signs of dehydration, especially if you experience vomiting or diarrhoea. Your Cured Pharmacy clinical team is available to support you throughout your treatment journey.

Mounjaro vs Ozempic: Clinical Differences Beyond Dosing

Beyond the dosing schedule, Mounjaro and Ozempic differ in their pharmacological profiles. Tirzepatide's dual GIP/GLP-1 action enhances insulin secretion more robustly than semaglutide alone, leading to greater improvements in glycaemic control and weight reduction in clinical trials [1]. The GIP component also influences fat metabolism and energy expenditure, contributing to Mounjaro's superior weight loss outcomes.

Both medications are administered as once-weekly subcutaneous injections using pre-filled KwikPens, making the practical administration very similar. However, injection volumes differ slightly—Mounjaro doses range from 0.5ml (2.5mg) to 0.5ml (15mg), whilst Ozempic volumes vary by strength. Patients generally find the transition straightforward from a practical injection technique perspective.

Cost considerations may also influence your decision to switch. Mounjaro is available at Cured Pharmacy from £135.00, with final pricing dependent on your prescribed maintenance dose following clinical assessment. Whilst both medications represent significant investments in your health, many patients find the enhanced efficacy of tirzepatide justifies the cost when Ozempic alone has not achieved their weight loss goals.

Who Is Suitable for Ozempic to Mounjaro Conversion?

Not every patient on Ozempic requires or benefits from switching to Mounjaro. Ideal candidates include those who have reached a weight loss plateau on maximum-dose Ozempic (2mg), patients seeking additional weight reduction beyond what semaglutide has delivered, or individuals who tolerated Ozempic well but wish to optimise their metabolic outcomes [2].

Conversely, patients experiencing excellent progress on Ozempic with minimal side effects may not need to switch. Your UK prescriber will assess whether conversion aligns with your clinical goals, medical history, and current response to treatment. Factors such as cardiovascular risk, diabetes status, and previous medication tolerability all inform this decision.

Certain medical conditions may influence suitability for Mounjaro. Patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 should not use tirzepatide or semaglutide [2]. Your free consultation at Cured Pharmacy includes a comprehensive medical screening to ensure Mounjaro is safe and appropriate for your individual circumstances.

Contraindications and Precautions

Both Ozempic and Mounjaro carry similar contraindications, including hypersensitivity to the active ingredients and the conditions mentioned above. If you have a history of pancreatitis, severe gastroparesis, or diabetic retinopathy complications, your prescriber will carefully evaluate whether switching medications is advisable or if additional monitoring is required.

Pregnancy and breastfeeding are contraindications for both medications. Women of childbearing potential should use effective contraception during treatment and discontinue tirzepatide at least two months before a planned pregnancy. Always inform your prescriber of any changes in your medical status or medications during your Mounjaro treatment.

How to Start Your Ozempic to Mounjaro Conversion at Cured Pharmacy

Beginning your conversion is straightforward at Cured Pharmacy. Start by completing our free online consultation, which takes under three minutes and covers your current Ozempic dose, weight loss history, medical background, and treatment goals. A UK-registered prescriber reviews your submission and determines whether Mounjaro is clinically appropriate for you.

If approved, you'll receive a prescription for your initial Mounjaro dose—typically 2.5mg for the first four weeks. Your medication is dispensed from our UK-registered pharmacy (GPhC 9012511) and delivered in 100% discreet packaging. Follow-up consultations ensure your dose is escalated safely according to your tolerance and clinical response, with ongoing prescriber support throughout your treatment journey.

Transparent upfront pricing means you'll see the cost before completing your consultation—no hidden fees or surprise charges. Our superintendent pharmacist, Tarun Kumar (GPhC 2233073), oversees all clinical services to ensure the highest standards of pharmaceutical care. If you have questions about your conversion, our clinical team is available on (+44) 116 4646009 during business hours.

Ongoing Monitoring and Dose Adjustments

Successful conversion requires regular clinical review. After your initial four-week period on 2.5mg, you'll complete a follow-up assessment before progressing to 5mg. This pattern continues as you escalate through 7.5mg, 10mg, 12.5mg, and potentially 15mg, with your prescriber evaluating weight loss, side effects, and overall tolerability at each stage.

Most patients reach their optimal maintenance dose within 16 to 24 weeks. Once established, you'll continue on that strength for as long as clinically appropriate, with periodic reviews to ensure ongoing safety and efficacy. Your Cured Pharmacy prescriber remains your partner throughout this process, adjusting your treatment plan as your needs evolve.

Scientific References

1. Frias, J. P., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes (SURPASS-2): A Randomised, Open-Label, Phase 3 Trial. The Lancet, 398(10295), 64–77. https://doi.org/10.1016/S0140-6736(21)01324-6
2. Medicines and Healthcare products Regulatory Agency (MHRA). (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen - Summary of Product Characteristics. Retrieved from https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency
3. Urva, S., et al. (2021). The Novel Dual Glucose-Dependent Insulinotropic Polypeptide and Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist Tirzepatide Transiently Delays Gastric Emptying Similarly to Selective Long-Acting GLP-1 Receptor Agonists. Diabetes Care, 44(10), 2231–2239. https://doi.org/10.2337/dc21-0285

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication or switching between treatments. Individual results may vary, and the information provided does not guarantee specific outcomes.